{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:18:40Z","timestamp":1788455920654,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112C-062, VGHUST112-G7-1-2"],"award-info":[{"award-number":["V112C-062, VGHUST112-G7-1-2"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC111-2314-B-A49A-509-MY3"],"award-info":[{"award-number":["NSTC111-2314-B-A49A-509-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Academia Sinica, Taiwan","award":["BM10501010039"],"award-info":[{"award-number":["BM10501010039"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Renal function decline is a frequently encountered complication in patients with chronic coronary syndrome. Aside from traditional cardiovascular risk factors, the inflammatory burden emerged as the novel phenotype that compromised renal prognosis in such population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cohort with chronic coronary syndrome was enrolled to investigate the association between inflammatory status and renal dysfunction. Levels of inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP), tumour necrosis factor-\u03b1 (TNF-\u03b1), adiponectin, matrix metalloproteinase-9, interleukin-6, lipoprotein-associated phospholipase A2, were assessed. Renal event was defined as &gt;\u200925% decline in estimated glomerular filtration rate (eGFR). Inflammatory scores were calculated based on the aggregate of hs-CRP, TNF-\u03b1, and adiponectin levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the 850 enrolled subjects, 145 patients sustained a renal event during an averaged 3.5 years follow-up. Multivariate analysis with Cox regression suggested elevations in hs-CRP, TNF-\u03b1, and adiponectin levels were independent risk factors for the occurrence of a renal event. Whereas, Kaplan-Meier curve illustrated significant correlation between high TNF-\u03b1 (<jats:italic>P<\/jats:italic>\u2009=\u20090.005), adiponectin (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), but not hs-CRP (<jats:italic>P<\/jats:italic>\u2009=\u20090.092), and eGFR decline. The aggregative effect of these biomarkers was also distinctly correlated with renal events (score 2: <jats:italic>P<\/jats:italic>\u2009=\u20090.042; score 3: <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Inflammatory burden was associated with eGFR decline in patients with chronic coronary syndrome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-023-03565-5","type":"journal-article","created":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T20:04:14Z","timestamp":1700165054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inflammation and renal function decline in chronic coronary syndrome: a prospective multicenter cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Ting-Wei","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Bang","family":"Leu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Kung","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung-I","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan-Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chau-Chung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"3565_CR1","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jacc.2016.12.005","volume":"69","author":"FA Masoudi","year":"2017","unstructured":"Masoudi FA, Ponirakis A, de Lemos JA, Jollis JG, Kremers M, Messenger JC, et al. Trends in U.S. Cardiovascular Care: 2016 Report from 4 ACC National Cardiovascular Data Registries. J Am Coll Cardiol. 2017;69:1427\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"3565_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","volume":"18","author":"K Stark","year":"2021","unstructured":"Stark K, Massberg S. Interplay between inflammation and Thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18:666\u201382.","journal-title":"Nat Rev Cardiol"},{"key":"3565_CR3","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1046\/j.1523-1755.2003.00762.x","volume":"63","author":"EM Stuveling","year":"2003","unstructured":"Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003;63:654\u201361.","journal-title":"Kidney Int"},{"key":"3565_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/hr.2010.154","volume":"33","author":"R Sauriasari","year":"2010","unstructured":"Sauriasari R, Sakano N, Wang DH, Takaki J, Takemoto K, Wang B, et al. C-reactive protein is associated with cigarette smoking-induced hyperfiltration and proteinuria in an apparently healthy population. Hypertens Res. 2010;33:1129\u201336.","journal-title":"Hypertens Res"},{"key":"3565_CR5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000504251","volume":"45","author":"J Gao","year":"2020","unstructured":"Gao J, Wang A, Li X, Li J, Zhao H, Zhang J, et al. The cumulative exposure to high-sensitivity C-reactive protein predicts the risk of chronic kidney Diseases. Kidney Blood Press Res. 2020;45:84\u201394.","journal-title":"Kidney Blood Press Res"},{"key":"3565_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12872-017-0471-z","volume":"17","author":"HB Leu","year":"2017","unstructured":"Leu HB, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh HI, et al. Identification of new biosignatures for clinical outcomes in stable coronary artery Disease - the study protocol and initial observations of a prospective follow-up study in Taiwan. BMC Cardiovasc Disord. 2017;17:42.","journal-title":"BMC Cardiovasc Disord"},{"key":"3565_CR7","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jdiacomp.2017.06.016","volume":"31","author":"A Schwandt","year":"2017","unstructured":"Schwandt A, Denkinger M, Fasching P, Pfeifer M, Wagner C, Weiland J, et al. Comparison of MDRD, CKD-EPI, and Cockcroft-Gault equation in relation to measured glomerular filtration rate among a large cohort with Diabetes. J Diabetes Complications. 2017;31:1376\u201383.","journal-title":"J Diabetes Complications"},{"key":"3565_CR8","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Chronic Kidney Disease Epidemiology Collaboration, et al. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med. 2021;385:1737\u201349.","journal-title":"N Engl J Med"},{"key":"3565_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63:713\u201335.","journal-title":"Am J Kidney Dis"},{"key":"3565_CR10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/01.ATV.21.6.961","volume":"21","author":"I Lemieux","year":"2001","unstructured":"Lemieux I, Pascot A, Prud\u2019homme D, Alm\u00e9ras N, Bogaty P, Nadeau A, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001;21:961\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3565_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/clpt.2009.311","volume":"87","author":"P Mathieu","year":"2010","unstructured":"Mathieu P, Lemieux I, Despr\u00e9s JP. Obesity, inflammation, and cardiovascular risk. Clin Pharmacol Ther. 2010;87:407\u201316.","journal-title":"Clin Pharmacol Ther"},{"key":"3565_CR12","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic Disease. N Engl J Med. 2017;377:1119\u201331.","journal-title":"N Engl J Med"},{"key":"3565_CR13","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1001\/jamacardio.2021.3079","volume":"6","author":"G Batra","year":"2021","unstructured":"Batra G, Ghukasyan Lakic T, Lindb\u00e4ck J, Held C, White HD, Stewart RAH, et al. STABILITY investigators. Interleukin 6 and cardiovascular outcomes in patients with chronic Kidney Disease and chronic coronary syndrome. JAMA Cardiol. 2021;6:1440\u20135.","journal-title":"JAMA Cardiol"},{"key":"3565_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fcvm.2018.00198","volume":"5","author":"I Santos-Zas","year":"2019","unstructured":"Santos-Zas I, Lemari\u00e9 J, Tedgui A, Ait-Oufella H. Adaptive immune responses contribute to post-ischemic cardiac remodeling. Front Cardiovasc Med. 2019;5:198.","journal-title":"Front Cardiovasc Med"},{"key":"3565_CR15","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.2215\/CJN.00710111","volume":"6","author":"J Bazeley","year":"2011","unstructured":"Bazeley J, Bieber B, Li Y, Morgenstern H, de Sequera P, Combe C, et al. C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:2452\u201361.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3565_CR16","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","volume":"91","author":"J Munoz Mendoza","year":"2017","unstructured":"Munoz Mendoza J, Isakova T, Cai X, Bayes LY, Faul C, Scialla JJ, et al. CRIC Study investigators. Inflammation and elevated levels of fibroblast growth factor 23 are Independent risk factors for death in chronic Kidney Disease. Kidney Int. 2017;91:711\u20139.","journal-title":"Kidney Int"},{"key":"3565_CR17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/CJN.13121215","volume":"11","author":"RL Amdur","year":"2016","unstructured":"Amdur RL, Feldman HI, Gupta J, Yang W, Kanetsky P, Shlipak M, et al. CRIC Study investigators. Inflammation and progression of CKD: the CRIC Study. Clin J Am Soc Nephrol. 2016;11:1546\u201356.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3565_CR18","doi-asserted-by":"publisher","first-page":"e0122073","DOI":"10.1371\/journal.pone.0122073","volume":"10","author":"N Neirynck","year":"2015","unstructured":"Neirynck N, Glorieux G, Schepers E, Verbeke F, Vanholder R. Soluble Tumor necrosis factor receptor 1 and 2 predict outcomes in advanced chronic Kidney Disease: a prospective cohort study. PLoS ONE. 2015;10:e0122073.","journal-title":"PLoS ONE"},{"key":"3565_CR19","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1038\/s41598-020-62465-2","volume":"10","author":"SH Song","year":"2020","unstructured":"Song SH, Oh TR, Choi HS, Kim CS, Ma SK, Oh KH, et al. High serum adiponectin as a biomarker of renal dysfunction: results from the KNOW-CKD study. Sci Rep. 2020;10:5598.","journal-title":"Sci Rep"},{"key":"3565_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.jjcc.2018.11.010","volume":"73","author":"H Gonz\u00e1lez-Pacheco","year":"2019","unstructured":"Gonz\u00e1lez-Pacheco H, Bojalil R, Amezcua-Guerra LM, Sandoval J, Eid-Lidt G, Arias-Mendoza A, et al. Derivation and validation of a simple inflammation-based risk score system for predicting in-hospital mortality in acute coronary syndrome patients. J Cardiol. 2019;73:416\u201324.","journal-title":"J Cardiol"},{"key":"3565_CR21","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1681\/ASN.2015060687","volume":"27","author":"CP Kovesdy","year":"2016","unstructured":"Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark DM, et al. CKD Prognosis Consortium. Past decline versus current eGFR and subsequent ESRD risk. J Am Soc Nephrol. 2016;27:2447\u201355.","journal-title":"J Am Soc Nephrol"},{"key":"3565_CR22","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1111\/jch.13956","volume":"22","author":"TW Kao","year":"2020","unstructured":"Kao TW, Huang CC, Chen JW. Optimal blood pressure for the prevention of hypertensive Nephropathy in nondiabetic hypertensive patients in Taiwan. J Clin Hypertens. 2020;22:1425\u201333.","journal-title":"J Clin Hypertens"},{"key":"3565_CR23","doi-asserted-by":"publisher","first-page":"e139927","DOI":"10.1172\/JCI139927","volume":"131","author":"J Puthumana","year":"2021","unstructured":"Puthumana J, Thiessen-Philbrook H, Xu L, Coca SG, Garg AX, Himmelfarb J, et al. Biomarkers of inflammation and repair in Kidney Disease progression. J Clin Invest. 2021;131:e139927.","journal-title":"J Clin Invest"},{"key":"3565_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s10916-017-0806-4","volume":"41","author":"AC McKown","year":"2017","unstructured":"McKown AC, Wang L, Wanderer JP, Ehrenfeld J, Rice TW, Bernard GR, et al. Predicting major adverse kidney events among critically ill adults using the electronic health record. J Med Syst. 2017;41:156.","journal-title":"J Med Syst"},{"key":"3565_CR25","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/ijms23020804","volume":"23","author":"TW Kao","year":"2022","unstructured":"Kao TW, Huang CC. Inflammatory burden and immunomodulative therapeutics of Cardiovascular Diseases. Int J Mol Sci. 2022;23:804.","journal-title":"Int J Mol Sci"},{"key":"3565_CR26","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"SM Nidorf","year":"2020","unstructured":"Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, et al. LoDoCo2 trial investigators. Colchicine in patients with chronic coronary Disease. N Engl J Med. 2020;383:1838\u201347.","journal-title":"N Engl J Med"},{"key":"3565_CR27","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"JC Tardif","year":"2019","unstructured":"Tardif JC, Kouz S, Waters DD, Bertrand OF, Diaz R, Maggioni AP, et al. Efficacy and safety of low-dose colchicine after Myocardial Infarction. N Engl J Med. 2019;381:2497\u2013505.","journal-title":"N Engl J Med"},{"key":"3565_CR28","doi-asserted-by":"publisher","first-page":"e008717","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","volume":"13","author":"B Shah","year":"2020","unstructured":"Shah B, Pillinger M, Zhong H, Cronstein B, Xia Y, Lorin JD, et al. Effects of acute colchicine administration prior to percutaneous coronary intervention: COLCHICINE-PCI randomized trial. Circ Cardiovasc Interv. 2020;13:e008717.","journal-title":"Circ Cardiovasc Interv"},{"key":"3565_CR29","doi-asserted-by":"publisher","first-page":"e008725","DOI":"10.1161\/JAHA.118.008725","volume":"7","author":"JM Rivera-Caravaca","year":"2018","unstructured":"Rivera-Caravaca JM, Ruiz-Nodar JM, Tello-Montoliu A, Esteve-Pastor MA, Quintana-Giner M, V\u00e9liz-Mart\u00ednez A, et al. Disparities in the estimation of glomerular filtration rate according to Cockcroft-Gault, modification of Diet in Renal Disease-4, and Chronic Kidney Disease Epidemiology Collaboration Equations and relation with outcomes in patients with acute coronary syndrome. J Am Heart Assoc. 2018;7:e008725.","journal-title":"J Am Heart Assoc"},{"key":"3565_CR30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/CIRCGENETICS.113.000173","volume":"7","author":"JM Kocarnik","year":"2014","unstructured":"Kocarnik JM, Pendergrass SA, Carty CL, Pankow JS, Schumacher FR, Cheng I, et al. Multiancestral analysis of inflammation-related genetic variants and C-reactive protein in the population architecture using genomics and epidemiology study. Circ Cardiovasc Genet. 2014;7:178\u201388.","journal-title":"Circ Cardiovasc Genet"},{"key":"3565_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/heartjnl-2014-306962","volume":"102","author":"R Rear","year":"2016","unstructured":"Rear R, Bell RM, Hausenloy DJ. Contrast-induced Nephropathy following angiography and cardiac interventions. Heart. 2016;102:638\u201348.","journal-title":"Heart"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03565-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03565-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T20:06:59Z","timestamp":1700165219000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03565-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3565"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03565-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the principles of the Declaration of Helsinki. It was approved by the independent ethics committees and independent review boards (IRBs) in each hospital, including Taipei Veterans General Hospital, Cheng-Hsin General Hospital, E-Da Hospital, Far Eastern Memorial Hospital, Kaohsiung Medical University Hospital, Mackay Memorial Hospital, China Medical University Hospital, Buddhist Tzu-Chi General Hospital, and National Taiwan University Hospital, as well as the Joint IRB Ethics Committees Review Boards in Taiwan (IRB: AS-IRB01-19007). Informed consent was obtained from all subjects before participating in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all subjects before participating in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"564"}}